Marta Nazarovets's questions to Seer Inc (SEER) leadership • Q4 2024
Question
Marta Nazarovets asked about the impact of recent NIH funding uncertainty on research customers and whether the company was seeing increased hesitation or changes in academic customer trends in early 2025. She also inquired about the publication pipeline for 2025 and any large-scale projects on the horizon.
Answer
Executive Omid Farokhzad noted that government and academic customers represented about 30% of 2024 revenue and that the 2025 guidance fully incorporates the cautious mindset stemming from NIH funding uncertainty. Executive David Horn added that early Q1 trends show this uncertainty is causing some project delays. Regarding publications, Omid Farokhzad expressed strong optimism, expecting the pace to continue accelerating in 2025, driven by the STAC program and highlighting recent presentations at the HUPO conference and a newly accepted nature-level paper from a customer.